SANA
Sana Biotechnology, Inc.
+0.29 (+9.93%)3.21USD1.3M成交股數961M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 30.7M | 28.7M | 30.1M | 29.8M | 37.2M | 45.1M | 53.2M | 60.9M | 56.4M | 65.6M | 73.0M | 67.2M |
| 銷售管理費用 | 10.8M | 11.5M | 10.3M | 10.3M | 11.5M | 17.3M | 14.1M | 16.4M | 16.3M | 19.2M | 16.6M | 16.8M |
| 營業利益 | −65.4M+29% | −48.6M-4% | −43.5M-30% | −95.0M+92% | −50.6M-54% | −50.9M+2232% | −61.8M-47% | −49.4M-41% | −111M | −2.2M | −116M | −84.1M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −63.6M+29% | −47.2M-4% | −42.2M-30% | −93.8M+87% | −49.4M-54% | −49.1M-5087% | −59.9M-47% | −50.3M-39% | −107M | 984K | −114M | −82.1M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.22+5% | -0.17-19% | -0.16-36% | -0.39+86% | -0.21-57% | -0.21 | -0.25-58% | -0.21-51% | -0.49 | 0.00 | -0.59 | -0.43 |
| 稀釋股數 | 296M | 277M | 260M | 238M | 238M | 231M | 235M | 234M | 217M | 200M | 193M | 191M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 57.1M | 83.8M | 103M | 71.3M | 96.1M | 128M | 127M | 135M | 177M | 168M | 174M | 160M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 432M | 374M | 435M | 362M | 445M | 501M | 559M | 619M | 681M | 631M | 707M | 747M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 277M | 254M | 240M | 239M | 236M | 251M | 267M | 279M | 306M | 266M | 352M | 319M |
| 股東權益 | 155M | 119M | 195M | 123M | 209M | 251M | 292M | 340M | 375M | 366M | 355M | 428M |
| 負債比 | 64.2% | 68.1% | 55.1% | 66.1% | 53.1% | 50.0% | 47.7% | 45.1% | 44.9% | 42.1% | 49.8% | 42.7% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −37.4M | – | – | −48.7M-26% | – | – | – | −65.6M | – | – | −79.3M |
| 資本支出 | – | 288K | – | – | 136K | – | – | – | 15.8M | – | – | 2.2M |
| 自由現金流 | – | −37.7M | – | – | −48.8M-40% | – | – | – | −81.5M | – | – | −81.4M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −244M | –% | -0.96 | −145M |
| FY2024 | – | – | −267M | –% | -1.16 | −257M |
| FY2023 | – | – | −283M | –% | -1.46 | −274M |
| FY2022 | – | – | −269M | –% | -1.43 | −311M |
| FY2021 | – | – | −356M | –% | -2.14 | −281M |
| FY2020 | – | – | −285M | –% | -21.92 | −162M |
| FY2019 | – | – | −131M | –% | -26.68 | −112M |